The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| VIEWRAY INC | COM | 92672L107 | 50,570 | 6,842,975 | SH | SOLE | 0 | 6,842,975 | 0 | ||
| EKSO BIONICS HLDGS INC | COM NEW | 282644202 | 51,543 | 20,534,898 | SH | SOLE | 0 | 20,534,898 | 0 | ||
| BELLEROPHON THERAPEUTICS INC | COM | 078771102 | 5,419 | 8,298,755 | SH | SOLE | 0 | 8,298,755 | 0 | ||
| KADMON HLDGS INC | COM | 48283N106 | 7,974 | 3,020,596 | SH | SOLE | 0 | 3,020,596 | 0 | ||
| TRACON PHARMACEUTICALS INC | COM | 89237H100 | 6,304 | 4,601,768 | SH | SOLE | 0 | 4,601,768 | 0 | ||
| CORVUS PHARMACEUTICALS INC | COM | 221015100 | 1,145 | 284,869 | SH | SOLE | 0 | 284,869 | 0 | ||